Cargando…
Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis
Multiple sclerosis (MS) is a degenerative disease of the central nervous system in which auto-immunity-induced demyelination occurs. MS is thought to be caused by a complex interplay of environmental and genetic risk factors. While most genetic studies have focused on identifying common genetic vari...
Autores principales: | Horjus, Julia, van Mourik-Banda, Tineke, Heerings, Marco A. P., Hakobjan, Marina, De Witte, Ward, Heersema, Dorothea J., Jansen, Anne J., Strijbis, Eva M. M., de Jong, Brigit A., Slettenaar, Astrid E. J., Zeinstra, Esther M. P. E., Hoogervorst, Erwin L. J., Franke, Barbara, Kruijer, Wiebe, Jongen, Peter J., Visser, Leo J., Poelmans, Geert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570223/ https://www.ncbi.nlm.nih.gov/pubmed/36232761 http://dx.doi.org/10.3390/ijms231911461 |
Ejemplares similares
-
Persistence and adherence in multiple sclerosis patients starting glatiramer acetate treatment: assessment of relationship with care received from multiple disciplines
por: Jongen, Peter Joseph, et al.
Publicado: (2016) -
Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
por: Visser, Leo H, et al.
Publicado: (2016) -
Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study)
por: Jongen, Peter Joseph, et al.
Publicado: (2017) -
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study
por: Jongen, Peter Joseph, et al.
Publicado: (2014) -
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
por: Jongen, Peter Joseph, et al.
Publicado: (2016)